Neil Abdollahian
CIK 1678223 · Chief Business Officer · last filed 2024-08-20
Neil Abdollahian is a Chief Business Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for BOLD, was dated Aug 20, 2024. Across all open-market trades the lifetime net is −$41.1K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
17
-$41.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BOLD | Chief Business Officer | — | $1.41 | — | $0 | 2 | 2024-08-20 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Chief Business Officer | 57,471 | $221.38 | $12.72M | -$41.1K | 15 | 2021-04-05 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-20 | BOLD | Mixed | — | $0 | EDGAR |
| 2024-03-29 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2021-04-05 | Cidara Therapeutics, Inc. (CDTX) Delisted | Mixed | −837 | -$9.8K | EDGAR |
| 2021-03-19 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | Cidara Therapeutics, Inc. (CDTX) Delisted | Sell (S) | −940 | -$3.2K | EDGAR |
| 2020-03-23 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-06 | Cidara Therapeutics, Inc. (CDTX) Delisted | Sell (S) | −2,340 | -$8.0K | EDGAR |
| 2019-12-20 | Cidara Therapeutics, Inc. (CDTX) Delisted | Mixed | — | $0 | EDGAR |
| 2019-10-03 | Cidara Therapeutics, Inc. (CDTX) Delisted | Sell (S) | −7,284 | -$14.4K | EDGAR |
| 2019-09-16 | Cidara Therapeutics, Inc. (CDTX) Delisted | Mixed | +22,400 | $0 | EDGAR |